BRCA1 and ovarian cancer: Through modified segregation analysis of 30 families, this variant was shown to have reduced penetrance, compared with the average penetrance truncating BRCA1 mutation (p = 0.0002), with estimated cumulative risks to age 70 of breast or ovarian cancer of 24%19.